Walleye Capital LLC Gilead Sciences, Inc. Put Options Transaction History

Walleye Capital LLC

$46.2 Billion
Q3 2024

Put Options

15 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$66.59 - $83.99 $246,383 - $310,763	-3,700 Reduced 6.51%	53,100 $4.45 Million
Q2 2024 Aug 14, 2024	SELL	$63.15 - $72.88 $3.16 Million - $3.65 Million	-50,100 Reduced 46.87%	56,800 $3.9 Million
Q1 2024 May 15, 2024	SELL	$71.58 - $87.29 $6.17 Million - $7.52 Million	-86,200 Reduced 44.64%	106,900 $7.83 Million
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $2.05 Million - $2.33 Million	-28,000 Reduced 12.66%	193,100 $15.6 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $10.8 Million - $11.7 Million	145,600 Added 192.85%	221,100 $16.6 Million
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $4.1 Million - $4.67 Million	53,900 Added 249.54%	75,500 $5.82 Million
Q1 2023 May 15, 2023	SELL	$77.31 - $88.08 $1.17 Million - $1.33 Million	-15,100 Reduced 41.14%	21,600 $1.79 Million
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $1.59 Million - $2.28 Million	25,500 Added 227.68%	36,700 $3.15 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $666,848 - $761,712	11,200 New	11,200 $691,000
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $36,170 - $42,000	-500 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $1.71 Million - $2.19 Million	-27,300 Reduced 98.2%	500 $37,000
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $4.1 Million - $4.51 Million	-66,500 Reduced 70.52%	27,800 $1.81 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $5.29 Million - $5.84 Million	84,600 Added 872.16%	94,300 $5.98 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $433,090 - $485,659	-7,000 Reduced 41.92%	9,700 $655,000
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $1.04 Million - $1.17 Million	16,700 New	16,700 $1.09 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.5 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$6.99 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.65 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.5 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $114B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Account